Latest Headlines

  1. Robot Compatible Solvent Removal Workstation 1/14/2020

    The new UltraVap Mistral XT 150 from Porvair Sciences provides unmatched automated dry down of organic solvent-based samples in tubes and microplates up to 150mm in length

  2. OGT Unveils Reliable Somatic CNV Detection For CLL With New NGS Panel 1/14/2020

    Oxford Gene Technology (OGT), A Sysmex Group Company, is excited to announce the launch of its SureSeq CLL + CNV Panel — the company’s latest high-quality, next-generation sequencing (NGS) offering for research into Chronic Lymphocytic Leukaemia (CLL).

  3. Mawi And CosmosID Collaborate To Enable More Precise Microbiome Analysis 1/13/2020

    Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces a collaboration with CosmosID to help advance understanding of microbiome complexity in different biological samples and environments

  4. Veravas And Tymora Collaborate On Early Detection Alzheimer’s Testing 1/13/2020

    Veravas, Inc. and Tymora Analytical Operations, LLC announced today that they have entered into a strategic alliance to explore the integration of their respective technologies

  5. Ovation Announces The Advent Of Automated System Validation To Ease Regulatory Burden Of Clinical Laboratory Teams 1/13/2020

    Ovation.io, Inc . (Ovation), a next-generation clinical informatics company and makers of the fastest growing clinical laboratory information and commercialization system, today announced a revolutionary new validation tool for clinical laboratories called Automated Systems Validation (ASV)

  6. Exosomics Implements NanoFCM’s NanoAnalyzer At Its Siena Facility To Provide Advanced Extracellular Vesicles-Focused Analytical Services 1/13/2020

    Exosomics SpA, the leading extracellular vesicles biotech company, today announced that it has implemented NanoFCM Co., Ltd’s NanoAnalyzer instrument to offer sophisticated contract research and measurement services worldwide

  7. MOgene Selects Fluidigm Advanta Assays And Juno System To Expand Its NGS Services Portfolio 1/13/2020

    MOgene, a leading provider of genomic and bioinformatic services in St. Louis, today announced it has selected Fluidigm’s (NASDAQ:FLDM) Advanta™ assays and microfluidics-based Juno™ system to expand its next-generation sequencing (NGS) services portfolio

  8. ProciseDx™ Announces CE Mark For Point Of Care Inflammatory Marker Assay 1/10/2020

    ProciseDx today announced the attainment of CE mark for its Procise CRP assay (C reactive protein) which is the first of its family of gastrointestinal markers. This follows the announcement of CE mark for the ProciseDx instrument in September 2019

  9. CareDx’s AlloSeq cfDNA Awarded CE Mark Approval 1/10/2020

    CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced that it has received CE mark approval for its AlloSeq cfDNA kit, making it broadly available to transplant patients and clinicians

  10. Oncocyte Announces Definitive Agreement To Acquire Insight Genetics 1/10/2020

    OncoCyte  Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the lung cancer care continuum, today announced that it has entered into an  agreement to acquire, through a subsidiary, all of the outstanding capital stock of privately-held Insight Genetics, Inc. (IG), which has a history of impactful discoveries in the areas of lung and breast cancer